drugset / Trial / NCT02457208
PK Study of Anti-TB Drugs
NaSingle-groupOpen-labelTreatment
Summary
This is a prospective descriptive and pharmacokinetic study will be conducted among newly diagnosed patients registered in the two SMRU TB clinics located on the Thai-Myanmar border. This study aims to recruit (1) 30 adults with HIV co-infection and (2) 30 adults without HIV co-infection in one year. Patients will be given the standard 6 month anti-TB drugs as per WHO guidelines.
Timeline
- Start
- 2015-07-07
- Primary completion
- 2018-01-14
- Completion
- 2018-01-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ethambutol | Small molecule | 275 mg | — |
| Subject | Isoniazid | Small molecule | 150 mg | — |
| Subject | Pyrazinamide | Small molecule | 400 mg | — |
| Subject | Rifampin | Small molecule | 300 mg | — |